Where Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38) is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Migraine | ↕ inconsistent | migraine patients (ictal jugular blood) | — | Riesco et al. 2017 |
Frequently asked questions
In which conditions is Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38) altered?
In the OSMF atlas Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38) is reported in Migraine. It is mixed in 1 across 1 entries.
Is there a standard clinical test for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38)?
The atlas entries for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP-38) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.